Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis C, Chronic × Ribavirin × Clear all

Phase

Phase 4 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Infections 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Seminoma 1 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hepatitis C, Chronic 1 Hepatitis C 1 Endodermal Sinus Tumor 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 daclatasvir 1 Viusid 1 Sofosbuvir 1 Simeprevir 1 Ribavirin 1 Dietary Supplements 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02771405 2016-05-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡